Trial site
Spitalul Universitar de Urgenta Militar Central 'Dr. Carol Davila'
- 17running trials
- 13closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Ulcerative colitis3 trials
- Bipolar disorder2 trials
- Crohn's disease2 trials
- Depression2 trials
- Heart failure2 trials
- Hidradenitis suppurativa2 trials
- Type 2 diabetes2 trials
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Cushing's syndrome1 trial
- Diabetic eye disease1 trial
- and 6 more
- Phase
- Phase 316 trials
- Phase 214 trials
- Status
- Completed13 trials
- Recruiting10 trials
- Active, not recruiting5 trials
- Not yet recruiting2 trials
- Lead sponsor
- Bristol-Myers Squibb5 trials
- Novartis Pharmaceuticals3 trials
- Amgen Inc.2 trials
- Intra-Cellular Therapies, Inc.2 trials
- Seaport Therapeutics2 trials
- and 15 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease6 recruiting
- Bipolar disorder2 recruiting
- Graves' disease1 recruiting
- Heart failure1 recruiting
- Hidradenitis suppurativa1 recruiting
- Schizophrenia1 recruiting
Closed trials
Enrolling by invitation
Recruiting
Completed
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Terminated
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
Terminated
A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
Completed
Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026